Mariner, LLC Intellia Therapeutics, Inc. Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Mariner, LLC holds 17,316 shares of NTLA stock, worth $231,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,316

Previous 15,494 11.76%

Holding current value

$231,688

Previous $346,000 2.6%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$19.72 - $27.36 $35,929 - $49,849	1,822 Added 11.76%	17,316 $355,000
Q2 2024 Aug 13, 2024	SELL	$20.02 - $27.22 $35,615 - $48,424	-1,779 Reduced 10.3%	15,494 $346,000
Q1 2024 May 15, 2024	BUY	$23.82 - $32.8 $11,100 - $15,284	466 Added 2.77%	17,273 $475,000
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $60,447 - $84,407	2,610 Added 18.38%	16,807 $512,000
Q3 2023 Nov 13, 2023	BUY	$31.62 - $45.78 $5,059 - $7,324	160 Added 1.14%	14,197 $448,000
Q2 2023 Aug 11, 2023	BUY	$34.58 - $46.03 $5,705 - $7,594	165 Added 1.19%	14,037 $572,000
Q1 2023 May 12, 2023	BUY	$33.3 - $44.82 $23,210 - $31,239	697 Added 5.29%	13,872 $516,000
Q4 2022 Feb 14, 2023	SELL	$33.21 - $62.69 $12,088 - $22,819	-364 Reduced 2.69%	13,175 $460,000
Q3 2022 Nov 10, 2022	SELL	$53.92 - $71.7 $200,636 - $266,795	-3,721 Reduced 21.56%	13,539 $758,000
Q2 2022 Aug 15, 2022	BUY	$38.49 - $76.21 $39,798 - $78,801	1,034 Added 6.37%	17,260 $894,000
Q1 2022 May 13, 2022	BUY	$58.27 - $118.99 $69,632 - $142,193	1,195 Added 7.95%	16,226 $1.18 Million
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $8,463 - $11,622	84 Added 0.56%	15,031 $1.78 Million
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $5,030 - $6,717	-38 Reduced 0.25%	14,947 $2.01 Million
Q2 2021 Aug 24, 2021	BUY	$60.88 - $161.91 $912,286 - $2.43 Million	14,985 New	14,985 $2.43 Million

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.02B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account